Long-Term Urinary and Sexual Outcomes in Pediatric Genitourinary Rhabdomyosarcoma Survivors: A Qualitative Study
- PMID: 39666941
- PMCID: PMC12254723
- DOI: 10.1097/JU.0000000000004374
Long-Term Urinary and Sexual Outcomes in Pediatric Genitourinary Rhabdomyosarcoma Survivors: A Qualitative Study
Abstract
Purpose: Genitourinary rhabdomyosarcoma (GU-RMS) often requires multimodal therapy treatment including radiation, chemotherapy, and radical surgery for disease control. The long-term effects of the disease and associated treatments are unclear. We sought to investigate the long-term genitourinary quality of life for adult survivors of pediatric GU-RMS.
Materials and methods: In total, 14 participants (43% female, median age = 32.5 years [IQR = 23.25-39.25], range = 20-52 years, 2 bladder, 1 cervical, 5 paratesticular, 3 vaginal, 2 pelvic, and 1 prostate RMS) agreed to interview about impact of GU-RMS treatment during childhood on quality of life. A semistructured interview guide based on the long-term service and support quality-of-life model and grounded in known GU-RMS experiences was created. Two coders independently coded using thematic analysis methodology.
Results: Six themes emerged: (1) unknown fertility status; (2) lack of education; (3) relationships and difficult communication; (4) incontinence, clean intermittent catheterization, and a bag; (5) lifestyle and learned adaptation; and (6) threats to body image. Across these themes, participants reported insufficient knowledge regarding GU-RMS treatment and its impact on function. Participants were principally concerned with anatomical changes, fertility, pregnancy expectations, and survivorship challenges such as communication with romantic partners.
Conclusions: Survivors of GU-RMS have significant urinary and sexual function concerns that are important to address in long-term survivorship. Clinicians can potentially improve survivors' quality of life through open and honest age-appropriate education on expectations for treatment, fertility preservation options, and long-term effects of treatment.
Keywords: quality of life; rhabdomyosarcoma; survivorship.
Conflict of interest statement
Comment in
-
Editorial Comment.J Urol. 2025 Apr;213(4):502. doi: 10.1097/JU.0000000000004399. Epub 2025 Jan 21. J Urol. 2025. PMID: 39836919 No abstract available.
-
Editorial Comment.J Urol. 2025 Apr;213(4):502-503. doi: 10.1097/JU.0000000000004442. Epub 2025 Feb 3. J Urol. 2025. PMID: 39898440 No abstract available.
-
The High Price to Pay for Survivorship of Genitourinary Rhabdomyosarcoma, Quality of Life.J Urol. 2025 Apr;213(4):405-406. doi: 10.1097/JU.0000000000004443. Epub 2025 Feb 5. J Urol. 2025. PMID: 39907146 No abstract available.
References
-
- Dasgupta R, Fuchs J and Rodeberg D: Rhabdomyosarcoma. Semin Pediatr Surg 2016; 25: 276–283. - PubMed
-
- Ferrari A, Bergamaschi L, Chiaravalli S, et al. : Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single‐center experience. Pediatr Blood Cancer 2022; 69. - PubMed
-
- Rhee DS, Rodeberg DA, Baertschiger RM, et al. : Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer Committee. J Pediatr Surg 2020; 55: 1987–1995. - PubMed
-
- Indelicato DJ, Rotondo RL, Krasin MJ, et al. : Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2020; 106: 968–976. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
